See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875622_2018_Biospecifics_Technologies_CORP.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000875622, Biospecifics Technologies CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 66,380,515 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 397,993 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 8,217,886 |
| 4 | LiabilitiesCurrent | 2,138,848 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,545,221 |
| 9 | ResearchAndDevelopmentExpense | 1,199,292 |
| 10 | remainder_Expenses | 7,038,104 |
| 11 | remainder_Revenues | 27,597,963 |
| 12 | remainder_NetIncome | 2,382,911 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 74,996,394 |
| 1 | Liabilities | 2,138,848 |
| 2 | Expenses | 16,782,617 |
| 3 | Revenues | 27,597,963 |
| 4 | StockholdersEquity | 72,857,546 |
| 5 | NetIncome | 13,198,257 |
| 6 | ComprehensiveNetIncome | 13,198,257 |
| 7 | BaseVar | 61,949,366 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.46 |
| 9 | EconomicCapitalRatio | 4.75 |
Edgar->Model Mapping
Feature Distribution
Change over Time
